Independent, source-led professional learningClinical content is date-stamped and reviewed
Account access is temporarily restricted.
The public website remains available while sign-in is limited to authorised staff.

Foundations of Prescribing for Non-Medical Prescribers

Preparing for an NMC-approved prescribing programme

Readiness, assessment/diagnostic capability, pharmacology/numeracy, AEI selection, supervised practice and portfolio.

Clinical safety: Use current guidance, local policy and patient-specific judgement.

Learning objectives

• Explain current capability-based readiness for NMC-approved prescribing education. • Identify clinical assessment, diagnostic, pharmacology and numeracy preparation needs. • Describe the roles of the AEI, employer and practice-learning partners. • Recognise the need for suitable supervised practice and assessment. • Build a realistic personal readiness and portfolio plan.

Section 1

Why this matters

Readiness, assessment/diagnostic capability, pharmacology/numeracy, AEI selection, supervised practice and portfolio.

Pre-prescribing foundation: this module develops knowledge and judgement for formal prescribing education; it does not authorise prescribing.

Section 2

Learning outcomes

  • Explain current capability-based readiness for NMC-approved prescribing education.
  • Identify clinical assessment, diagnostic, pharmacology and numeracy preparation needs.
  • Describe the roles of the AEI, employer and practice-learning partners.
  • Recognise the need for suitable supervised practice and assessment.
  • Build a realistic personal readiness and portfolio plan.

Section 3

Core concepts

Current NMC readiness is not based on a fixed minimum registration period; AEIs assess skills, knowledge and experience.

Applicants should be able to evidence clinical assessment, diagnostics, care management and planning/evaluation of care at a level appropriate to the intended prescribing area.

Employer, AEI and practice placement partners commonly share responsibility for selection and learning support.

All practice-learning components and pharmacology/numeracy assessments remain required even where prior learning is recognised.

Applied scenarios

An experienced nurse has strong specialty expertise but limited diagnostic assessment experience.

An employer nominates a nurse for a course but cannot provide suitable supervised practice.

Section 4

Safe prescribing decision pathway

  1. Define the clinical problem and whether prescribing is indicated.
  2. Gather the patient-specific assessment and diagnostic information needed.
  3. Check competence, professional authority and employer/service scope.
  4. Compare reasonable options using current authoritative sources.
  5. Agree the plan with the patient, including uncertainty and alternatives.
  6. Prescribe accurately only when the decision is justified.
  7. Document, monitor, review and safety-net.

Module emphasis: Use the AEI and employer requirements to identify readiness gaps, secure appropriate supervised practice and build evidence in assessment, diagnostics, pharmacology and numeracy.

Section 5

Apply it

Scenario 1. An experienced nurse has strong specialty expertise but limited diagnostic assessment experience.

Reasoning prompt: For each scenario, identify the readiness gap, who should address it (learner, employer, approved education institution or practice-learning partner), and what evidence or support is needed before or during formal prescribing education.

Scenario 2. An employer nominates a nurse for a course but cannot provide suitable supervised practice.

Reasoning prompt: For each scenario, identify the readiness gap, who should address it (learner, employer, approved education institution or practice-learning partner), and what evidence or support is needed before or during formal prescribing education.

Section 6

Common traps

  • A legal entitlement to prescribe means the person is competent for every medicine and condition.
  • Electronic prescribing systems remove the need for clinical checking.
  • If a medicine appears in a formulary or BNF, it is automatically appropriate for the patient.
  • Completing an educational programme is the same as professional authorisation to prescribe.

Section 7

Practice checklist

  • What clinical problem am I trying to solve, and is prescribing indicated?
  • What information is missing before a safe decision can be made?
  • What regulator route/annotation applies, and what separate employer/service authorisation is required?
  • Which current authoritative medicine or guideline source should I check?
  • What patient-specific factors change benefit, harm, dose, route or monitoring?
  • What will I document, monitor, review and safety-net?
  • When should I seek supervision, pharmacy advice, specialist input or urgent escalation?

Optional reflection: Without entering identifiable patient or employer information, identify one capability you would need to strengthen before prescribing independently in this area.

Section 8

Key points

  • Current NMC readiness is not based on a fixed minimum registration period; AEIs assess skills, knowledge and experience.
  • Applicants should be able to evidence clinical assessment, diagnostics, care management and planning/evaluation of care at a level appropriate to the intended prescribing area.
  • Employer, AEI and practice placement partners commonly share responsibility for selection and learning support.
  • All practice-learning components and pharmacology/numeracy assessments remain required even where prior learning is recognised.

Section 9

Official sources and further reading

Check current versions for time-sensitive decisions.

Section 10

Downloadable learner reading PDF

Open source ↗
© 2026 Clinical EducationWebsite is a project by SAS Doctors · sasdoctors.com · editor@clinicaledu.ukVisitors today: 4Protected by Cloudflare